Atomera Inc (ATOM)

Insider Trading Filed: 2026-05-13

Director John Gerber acquired 14,302 Restricted Stock Units (RSUs) on May 12, 2026, vesting one year later, indicating company confidence in future prospects and executive compensation alignment with shareholders.
Gerber maintains substantial beneficial ownership of 608,857 common shares across multiple holdings (direct, via partnership, and through spouse/spouse's IRA), demonstrating significant personal financial commitment to Atomera.
The RSU grant at $0.00 price represents a standard equity compensation package rather than open market purchases, which is typical for director compensation but does not signal insider confidence about undervaluation.

Insider Trading Filed: 2026-05-13

Director Duy-Loan T. Le received 14,302 Restricted Stock Units (RSUs) on May 12, 2026, vesting one year later on May 11, 2027, indicating standard equity compensation for board members rather than open market purchases.
The $0.00 transaction price confirms these are compensation-based RSU grants rather than stock purchases, representing no out-of-pocket investment by the insider and suggesting confidence in future value only.
Le's total beneficial ownership increased to 134,460 shares following this grant, demonstrating meaningful stake alignment with shareholders, though the timing and structure are routine equity comp rather than discretionary insider buying.

Insider Trading Filed: 2026-05-13

Director Ramnath Suja received 14,302 restricted stock units (RSUs) on May 12, 2026, vesting one year later on May 11, 2027, indicating continued equity compensation for board-level participation.
The RSUs were granted at $0.00 price, typical for RSU grants based on fair market value recognition, and represent standard equity incentive compensation rather than a market purchase.
Suja's total beneficial ownership increased to 86,740 common shares following this transaction, demonstrating continued alignment between insider and shareholder interests.
This is a routine equity grant rather than an insider buy or sell signal, with no material trading activity that would suggest directional conviction about the stock's valuation.

Insider Trading Filed: 2026-05-13

Director Steven K. Shevick acquired 14,302 Restricted Stock Units (RSUs) on May 12, 2026, with a one-year vesting period until May 11, 2027, indicating recent equity compensation typical for board members.
The transaction occurred at $0.00 price per the filing footnote, reflecting RSU issuance rather than open market purchase, which is routine equity incentive compensation and not indicative of insider conviction about stock price direction.
Shevick's total beneficial ownership increased to approximately 142,518 shares directly owned plus 2,200 shares indirectly held through the Mackenzie Shevick Trust, maintaining a meaningful stake in the company.
The filing is routine in nature with no material transactions, secondary offerings, or unusual timing patterns that would suggest significant insider sentiment or material non-public information.

Current Report Filed: 2026-05-13

All five directors were re-elected to the Board with strong support, with vote totals ranging from 11.9M to 12.3M 'For' votes, indicating solid shareholder confidence in current leadership.
Shareholders approved an increase in authorized common stock shares with 20.98M votes in favor versus 2.14M against (90.7% approval rate), suggesting the company is preparing for potential capital needs or strategic initiatives.
Executive compensation was approved by advisory vote with 11.52M for versus 1.52M against (88.3% approval), demonstrating shareholder acceptance of current pay practices despite some dissent.
The independent auditor CBIZ CPAs P.C. was overwhelmingly ratified with 22.83M votes for and minimal opposition (229K against), reflecting confidence in audit quality and financial reporting controls.

Current Report Filed: 2026-02-24

Atomera Inc. has announced a $25 million registered direct offering of 5 million shares of common stock at $5 per share, which will provide additional working capital and funding for general corporate purposes.
The company has entered into a Securities Purchase Agreement with institutional investors and a Placement Agent Agreement with Craig-Hallum Capital Group to facilitate the offering.
Atomera has also secured 90-day lock-up agreements from its executive officers and directors, indicating confidence in the company's growth prospects.

Annual Report Filed: 2026-02-24

Atomera Inc. reported significant year-over-year revenue growth in 2025, driven by increased sales to its two largest customers.
The company maintained a strong cash and investment position, with over $100 million in liquid assets as of the end of 2025.
Atomera continued to invest heavily in research and development, as well as selling and marketing efforts, to support its growth strategy.

Current Report Filed: 2026-02-12

Atomera Incorporated reported its financial results for the three and twelve months ended December 31, 2025, providing an update on the company's progress.
The company intends to conduct an earnings call and distribute an investor presentation to discuss the financial results in more detail.
Investors should review the press release and investor presentation to understand the company's performance, outlook, and any material developments.

Current Report Filed: 2026-02-11

Atomera Incorporated amended its bylaws to reduce the quorum requirement for shareholder meetings from a majority to one-third of outstanding voting shares. This change could make it easier to reach a quorum and pass resolutions.
The company also amended the voting requirement for matters other than director elections, changing from a majority of votes present to a majority of votes cast, and explicitly treating abstentions and broker non-votes as not counted. This could affect the outcome of future shareholder votes.
The bylaw changes appear to be technical in nature and do not indicate any immediate material impact on the company's operations or financial performance.

Important Information